Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 292

    1.

    Feasibility of automating insulin delivery for the treatment of type 1 diabetes.

    Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF.

    Diabetes. 2006 Dec;55(12):3344-50.PMID: 17130478 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.

    Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.

    Diabetes Care. 2008 May;31(5):934-9. Epub 2008 Feb 5.PMID: 18252903 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

    Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T.

    Pediatr Diabetes. 2007 Jun;8(3):157-62.PMID: 17550426 [PubMed - indexed for MEDLINE]Related articles

    5.

    Subcutaneous open-loop insulin delivery for type 1 diabetes: Paradigm Real-Time System.

    Pohar SL.

    Issues Emerg Health Technol. 2007 Oct;(105):1-6.PMID: 17953047 [PubMed - indexed for MEDLINE]Related articles

    6.

    Glycemic control with closed-loop intraperitoneal insulin in type I diabetes.

    LeBlanc H, Chauvet D, Lombrail P, Robert JJ.

    Diabetes Care. 1986 Mar-Apr;9(2):124-8.PMID: 3516606 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    8.

    Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

    Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

    Diabetes Technol Ther. 2007 Aug;9(4):339-47.PMID: 17705689 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes.

    Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, Rosenbloom AL.

    Diabetes Technol Ther. 2007 Aug;9(4):372-6.PMID: 17705693 [PubMed - indexed for MEDLINE]Related articles

    10.

    Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system.

    Panteleon AE, Loutseiko M, Steil GM, Rebrin K.

    Diabetes. 2006 Jul;55(7):1995-2000.PMID: 16804068 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.

    Schaller HC, Schaupp L, Bodenlenz M, Wilinska ME, Chassin LJ, Wach P, Vering T, Hovorka R, Pieber TR.

    Diabet Med. 2006 Jan;23(1):90-3.PMID: 16409572 [PubMed - indexed for MEDLINE]Related articles

    13.

    The rate of improvement in metabolic control in children with diabetes mellitus type 1 on insulin glargine depends on age.

    Deja G, Jarosz-Chobot P, Polanska J.

    Exp Clin Endocrinol Diabetes. 2007 Nov;115(10):662-8.PMID: 18058601 [PubMed - indexed for MEDLINE]Related articles

    14.

    Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system.

    Cengiz E, Swan KL, Tamborlane WV, Steil GM, Steffen AT, Weinzimer SA.

    Diabetes Technol Ther. 2009 Apr;11(4):207-10.PMID: 19344194 [PubMed - indexed for MEDLINE]Related articles

    15.

    The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes.

    Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MW.

    Diabetes. 2005 Apr;54(4):1100-7.PMID: 15793249 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    24-hour blood glucose profiles in insulin-dependent diabetics treated with intravenous insulin infusion systems. A comparison between closed- and open-loop systems.

    Deckert T, Bojsen J, Christiansen JS, Kølendorf K, Svendsen PA, Andersen AR.

    Acta Med Scand. 1980;208(6):451-8.PMID: 7008508 [PubMed - indexed for MEDLINE]Related articles

    18.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software.

    Garg SK, Bookout TR, McFann KK, Kelly WC, Beatson C, Ellis SL, Gutin RS, Gottlieb PA.

    Diabetes Technol Ther. 2008 Oct;10(5):369-75.PMID: 18715213 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.

    Porcellati F, Rossetti P, Busciantella NR, Marzotti S, Lucidi P, Luzio S, Owens DR, Bolli GB, Fanelli CG.

    Diabetes Care. 2007 Oct;30(10):2447-52. Epub 2007 Jul 10. Erratum in: Diabetes Care. 2008 Jan;31(1):188. PMID: 17623819 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data